Emerging antiviral targets for influenza A virus.

The potential threat of a pandemic caused by H5N1 influenza A viruses has stimulated increased research on developing new antivirals against influenza A viruses. Current antivirals are directed against the M2 protein (named adamantanes) and the neuraminidase (named zanamivir and oseltamivir). However, both seasonal and H5N1 influenza A viruses have developed resistance to adamantanes and oseltamivir. Accordingly, new antivirals directed at the M2 and neuraminidase proteins, and against the hemagglutinin protein, are being developed. In addition, elucidation of the structural basis for several crucial functions of other viral proteins (specifically the non-structural NS1A protein, the nucleoprotein and the viral polymerase) has identified novel targets for the development of new antivirals. Here, we describe how functional and structural studies led to the discovery of these novel targets and also how structural information is facilitating the rational design of new drugs against previously identified targets.

[1]  Helen M. Berman,et al.  Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein , 1997, Nature Structural Biology.

[2]  R. Fukuda,et al.  Binding of influenza A virus NS1 protein to dsRNA in vitro. , 1992, The Journal of general virology.

[3]  C. Macken,et al.  Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  I D Kuntz,et al.  Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity , 1997, Journal of virology.

[5]  R. Webster,et al.  Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. , 1995, Virology.

[6]  Yoshihiro Kawaoka,et al.  Influenza: lessons from past pandemics, warnings from current incidents , 2005, Nature Reviews Microbiology.

[7]  J. Skehel,et al.  The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.

[8]  Liang Tong,et al.  Conserved Surface Features Form the Double-stranded RNA Binding Site of Non-structural Protein 1 (NS1) from Influenza A and B Viruses* , 2007, Journal of Biological Chemistry.

[9]  Cinque S. Soto,et al.  Structural basis for the function and inhibition of an influenza virus proton channel , 2008, Nature.

[10]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[11]  R. Krug,et al.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[13]  J. Chou,et al.  Structure and mechanism of the M2 proton channel of influenza A virus , 2008, Nature.

[14]  R. Lamb,et al.  16 The Influenza A Virus M2 Ion Channel Protein and Its Role in the Influenza Virus Life Cycle , 1994 .

[15]  Yan Zhou,et al.  Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. , 2007, The Journal of general virology.

[16]  M. Katze,et al.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. , 1995, Virology.

[17]  James M Aramini,et al.  Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. , 2004, Biochemistry.

[18]  R. Webster,et al.  A pandemic warning? , 1997, Nature.

[19]  J. Skehel,et al.  Molecular basis of resistance of influenza A viruses to amantadine. , 1986, The Journal of antimicrobial chemotherapy.

[20]  G. Montelione,et al.  Structural basis for suppression of a host antiviral response by influenza A virus , 2008, Proceedings of the National Academy of Sciences.

[21]  Joe D. Lewis,et al.  The structural basis for cap binding by influenza virus polymerase subunit PB2 , 2008, Nature Structural &Molecular Biology.

[22]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[23]  R. Krug,et al.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. , 2007, Virology.

[24]  Pang-Chui Shaw,et al.  Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  P. Digard,et al.  The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. , 2002, The Journal of general virology.

[26]  Sek-Man Wong,et al.  Structural basis for dsRNA recognition by NS1 protein of influenza A virus , 2009, Cell Research.

[27]  R. Krug,et al.  Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: Outcome with influenza A virus is unique , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Prasert Auewarakul,et al.  Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. , 2005, The Journal of general virology.

[29]  H. Oshitani,et al.  Emergence of amantadine-resistant influenza A viruses: epidemiological study , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[30]  Ronald Frank,et al.  Peptide-Mediated Interference with Influenza A Virus Polymerase , 2007, Journal of Virology.

[31]  A. Nizam,et al.  Containing Pandemic Influenza at the Source , 2005, Science.

[32]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[33]  R. Sidwell,et al.  Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection , 1998, Antimicrobial Agents and Chemotherapy.

[34]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[35]  G. Montelione,et al.  A novel RNA-binding motif in influenza A virus non-structural protein 1 , 1997, Nature Structural Biology.

[36]  J. Taubenberger,et al.  The 1918 Spanish influenza: integrating history and biology. , 2001, Microbes and infection.

[37]  R. Webster,et al.  Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo , 2007, Journal of Virology.

[38]  R. Krug,et al.  Influenza virus virulence and its molecular determinants. , 2005, Advances in virus research.

[39]  R. Krug,et al.  Interaction of the Influenza A Virus Nucleocapsid Protein with the Viral RNA Polymerase Potentiates Unprimed Viral RNA Replication , 2008, Journal of Virology.

[40]  M. Zambon,et al.  Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  Andrew A. McCarthy,et al.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit , 2009, Nature.

[42]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[43]  F. Hayden,et al.  Antivirals for influenza: historical perspectives and lessons learned. , 2006, Antiviral research.

[44]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[45]  R. Webster,et al.  Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. , 2006, Antiviral research.

[46]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[47]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[48]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[49]  R. Krug,et al.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.

[50]  Zihe Rao,et al.  Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site , 2009, Nature.

[51]  A. Joachimiak,et al.  Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virus , 2008, Nature.

[52]  N. Cox,et al.  Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. , 2007, The Journal of infectious diseases.

[53]  B. G. Hale,et al.  Structure of an avian influenza A virus NS1 protein effector domain. , 2008, Virology.

[54]  Xianghong Jing,et al.  Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel , 2008, Proceedings of the National Academy of Sciences.

[55]  B. G. Hale,et al.  The multifunctional NS1 protein of influenza A viruses. , 2008, The Journal of general virology.

[56]  Ralph S. Baric,et al.  Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function , 2008, Journal of Virology.

[57]  S. Cady,et al.  Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding. , 2009, Journal of molecular biology.

[58]  A. Monzingo,et al.  Structure of NS1A effector domain from the influenza A/Udorn/72 virus. , 2009, Acta crystallographica. Section D, Biological crystallography.

[59]  David J Stevens,et al.  Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion , 2008, Proceedings of the National Academy of Sciences.

[60]  R. Krug,et al.  The Influenza Viruses , 2011, The Viruses.

[61]  Rei-Lin Kuo,et al.  The CPSF30 Binding Site on the NS1A Protein of Influenza A Virus Is a Potential Antiviral Target , 2006, Journal of Virology.

[62]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[63]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[64]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[65]  N. Meanwell,et al.  Structure-activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-trimethyl-5-hydroxy-cyclohexylmethylamine. , 2002, Bioorganic & medicinal chemistry letters.

[66]  I D Kuntz,et al.  Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. , 1993, Biochemistry.

[67]  G. Montelione,et al.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. , 1999, RNA.

[68]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[69]  Richard E. Randall,et al.  Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling , 2006, Proceedings of the National Academy of Sciences.

[70]  R. Krug,et al.  The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA , 2006, Nature.

[71]  E. Obayashi,et al.  The structural basis for an essential subunit interaction in influenza virus RNA polymerase , 2008, Nature.

[72]  G. Karupiah,et al.  FIELDS VIROLOGY, 4TH EDITION , 2002 .

[73]  R. Krug,et al.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. , 2003, Virology.

[74]  M. Katze,et al.  Expression and Replication of the Influenza Virus Genome , 1989 .

[75]  B. Prasad,et al.  X-ray structure of influenza virus NS1 effector domain , 2006, Nature Structural &Molecular Biology.